BioNTech to Present Clinical Data Updates Across mRNA and Immunomodulatory Oncology Portfolio at ESMO Congress 2024
MAINZ, Germany, September 05, 2024 - BioNTech SE ( Nasdaq: BNTX, "BioNTech" or "the Company" ) will present clinical trial data for selected assets from its multi-platform oncology pipeline at the European Society for Molecular Oncology ( "ESMO" ) Congress 2024 in Barcelona, Spain from September ...
| Ticker |
Sentiment |
Impact |
|
ADCT
|
Neutral
|
2 %
|
|
FOSUF
|
Neutral
|
2 %
|
|
GMAB
|
Neutral
|
2 %
|
|
PFE
|
Neutral
|
2 %
|
|
BNTX
|
Neutral
|
26 %
|
|
BNXYF
|
Neutral
|
2 %
|
